Aarti Drugs Board of Directors
Get the latest insights into the leadership at Aarti Drugs. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Rushikesh Deole | Company Secretary & Compliance Officer |
| Chandrakant V Gogri | Chairman Emeritus |
| Prakash M Patil | Chairman & Managing Director & CEO |
| Rashesh C Gogri | Managing Director |
| Harshit M Savla | Joint Managing Director |
| Harit P Shah | Whole Time Director |
| Uday M Patil | Whole Time Director |
| Ankit Paleja | Non Executive Independent Director |
| Bhaskar Narayan Thorat | Non Executive Independent Director |
| Neha R Gada | Non Executive Independent Director |
| Hasmukh Dedhia | Non Executive Independent Director |
| Sandeep M Joshi | Non Executive Independent Director |
| Ajit Eledath Venugopalan | Non Executive Independent Director |
| Narendra J Salvi | Non Executive Director |
Aarti Drugs FAQs
The board at Aarti Drugs consists of experienced professionals, including Rushikesh Deole, Chandrakant V Gogri, and others, overseeing the company’s strategic and corporate governance.
Directors at Aarti Drugs are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Rushikesh Deole is the current chairman at Aarti Drugs.
Executive directors at Aarti Drugs are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Aarti Drugs adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Aarti Drugs, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
